This Fall 2020 issue – Volume 10, Issue 1 – contains works exploring a multitude of continuing and […]
Barton Beebe* Download a PDF version of this article here. Watch our second episode of The Author Series […]
Zachary J. Bass, Ashley C. Ulrich, Ryan B. McLeod, Kevin Qiao, Joanne Dynak, Lvxiao Chen, Garrett Heller, Minyoung […]
Ashley Ulrich* Download a PDF of this article here. Introduction I. Antitrust Enforcement and Procompetetive Justifications A. Introduction […]
Richard Chused* Download a PDF of this article here. Introduction I. A Tale of Compositional Conflict A. A […]
Recently, state governments have begun to claim a copyright interest in their official published codes of law, in particular arguing that ancillary
materials such as annotations to the statutory text are subject to state-held copyright protection because those materials are not binding commands that carry the force of law.
Patent term extension (PTE) is a statutorily-based mechanism to compensate inventors for patent term loss due to regulatory delay during the drug approval process at the United States Food and Drug Administration (FDA). In the context of pharmaceutical products, PTE is only available for the active ingredient of a drug formulation.
Some perceive trademark protection as a reward for a mark owner’s labor in cultivating his business goodwill. However, among legal scholars and academics, the prevailing theoretical explanation for trademark protection is utilitarian, focusing on increasing consumer welfare.
Mickey Mouse, the iconic mascot of the Walt Disney Company, is one of the most recognizable and beloved characters in the world.
Our Spring 2020 issue, Volume 9, Issue 2, is comprised of five individual pieces that explore significant, current themes in intellectual property and entertainment law, ranging from providing guidance from practice and experience, to questioning the very underlying legal framework of trademark law.